Cowen and Company’s Bellevue Life Sciences Acquisition Corp. Rights BLACR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-323,252	Closed	-$35.3K	–	436
2024 Q3	$35.3K	Buy	323,252 +73,397	+29%	+$8.02K	﹤0.01%	329
2024 Q2	$25K	Buy	+249,855	New	+$25K	﹤0.01%	349
2023 Q2	–	Sell	-125,100	Closed	-$22.5K	–	625
2023 Q1	$22.5K	Buy	+125,100	New	+$22.5K	﹤0.01%	285